Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Molly G Minze

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Core Evidence|February 7, 2015
Dulaglutide: an evidence-based review of its potential in the treatment of type 2 diabetesKrystal L Edwards, Molly G Minze
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|January 28, 2014
Drug treatment of type 2 diabetes mellitus in patients for whom metformin is contraindicatedBrian K Irons, Molly G Minze
Therapeutics and Clinical Risk Management|April 22, 2016
Combination therapies in the management of type 2 diabetes: the use of insulin degludec/liraglutideMolly G Minze, Lisa M Chastain
The Journal of Family Practice|October 7, 2011
Removing barriers to insulin useMolly G Minze, Kavita Dalal, Brian K Irons
Clinical Medicine Insights. Endocrinology and Diabetes|August 23, 2013
Saxagliptin and metformin in fixed combination for the treatment of type 2 diabetes in adultsMolly G Minze, Mary S Klein, Brian T Terrell
The Journal of Pharmacy Technology : Jpt : Official Publication of the Association of Pharmacy Technicians|December 3, 2021
Low-Molecular-Weight Heparin Prophylaxis Dosing: Is Weight an Issue?Molly G Minze, Yu-Yu Kwee, Ronald G Hall
American Journal of Pharmaceutical Education|August 16, 2025
State of the Academy-Challenges to Student SuccessMolly G Minze, James M Culhane, Evan T Robinson
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|February 21, 2016
Achieving cholesterol goals with low-cost 3-hydroxy-3-methylglutaryl coenzyme-A (HMG Co-A) reductase inhibitorsMary S Klein, Robin L Koffarnus, Molly G Minze, et al.
Expert Review of Endocrinology & Metabolism|October 6, 2018
Sodium-glucose co-transporter 2 inhibitors: evidence and place in therapyMolly G Minze, Robin L Koffarnus, Trista A Bailey, et al.
American Journal of Pharmaceutical Education|March 19, 2022
An Evaluation of Nonacademic Predictors of Success in a Doctor of Pharmacy ProgramCharles F Seifert, Rebecca J Mahan, Monica Mathys, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Core Evidence|February 7, 2015
Dulaglutide: an evidence-based review of its potential in the treatment of type 2 diabetesKrystal L Edwards, Molly G Minze
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|January 28, 2014
Drug treatment of type 2 diabetes mellitus in patients for whom metformin is contraindicatedBrian K Irons, Molly G Minze
Therapeutics and Clinical Risk Management|April 22, 2016
Combination therapies in the management of type 2 diabetes: the use of insulin degludec/liraglutideMolly G Minze, Lisa M Chastain
The Journal of Family Practice|October 7, 2011
Removing barriers to insulin useMolly G Minze, Kavita Dalal, Brian K Irons
Clinical Medicine Insights. Endocrinology and Diabetes|August 23, 2013
Saxagliptin and metformin in fixed combination for the treatment of type 2 diabetes in adultsMolly G Minze, Mary S Klein, Brian T Terrell
The Journal of Pharmacy Technology : Jpt : Official Publication of the Association of Pharmacy Technicians|December 3, 2021
Low-Molecular-Weight Heparin Prophylaxis Dosing: Is Weight an Issue?Molly G Minze, Yu-Yu Kwee, Ronald G Hall
American Journal of Pharmaceutical Education|August 16, 2025
State of the Academy-Challenges to Student SuccessMolly G Minze, James M Culhane, Evan T Robinson
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|February 21, 2016
Achieving cholesterol goals with low-cost 3-hydroxy-3-methylglutaryl coenzyme-A (HMG Co-A) reductase inhibitorsMary S Klein, Robin L Koffarnus, Molly G Minze, et al.
Expert Review of Endocrinology & Metabolism|October 6, 2018
Sodium-glucose co-transporter 2 inhibitors: evidence and place in therapyMolly G Minze, Robin L Koffarnus, Trista A Bailey, et al.
American Journal of Pharmaceutical Education|March 19, 2022
An Evaluation of Nonacademic Predictors of Success in a Doctor of Pharmacy ProgramCharles F Seifert, Rebecca J Mahan, Monica Mathys, et al.
Pageof 2